Er-Kim and Sentynl Therapeutics Partner to Expand Access to Rare Disease Treatments in EMEA and Eurasian Markets Read more
Biostar Pharma’s Utidelone Receives Third Orphan Drug Designation from FDA for Pancreatic Cancer Read more
Cellectar Biosciences Partners with Evestia Clinical for Phase 1b Trial of CLR 125 in Triple-Negative Breast Cancer Read more